메뉴 건너뛰기




Volumn 345, Issue 11, 2001, Pages 810-816

Changing the status of drugs from prescription to over-the-counter availability

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIARRHEAL AGENT; ANTIFUNGAL AGENT; ANTILIPEMIC AGENT; CIMETIDINE; CLOTRIMAZOLE; DECONGESTIVE AGENT; DIPHENHYDRAMINE; FAMOTIDINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IBUPROFEN; KETOCONAZOLE; KETOPROFEN; LOPERAMIDE; MINOXIDIL; NAPROXEN; NEW DRUG; NICOTINE; NICOTINE GUM; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PSEUDOEPHEDRINE; RANITIDINE;

EID: 0035856022     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra011080     Document Type: Review
Times cited : (142)

References (22)
  • 4
    • 0028931097 scopus 로고
    • An assessment of the safety of pediatric ibuprofen: A practitioner-based randomized clinical trial
    • (1995) JAMA , vol.273 , pp. 929-933
    • Lesko, S.M.1    Mitchell, A.A.2
  • 5
    • 0025731444 scopus 로고
    • Implications of the reclassification of drugs from prescription-only to over-the-counter status
    • (1991) Clin Ther , vol.13 , pp. 200-215
    • Gossel, T.A.1
  • 6
    • 0032418994 scopus 로고    scopus 로고
    • American Pharmaceutical Association review of literature on prescription to over-the-counter drug switches
    • (1998) Clin Ther , vol.20 , Issue.SUPPL. C
    • Schulke, D.G.1
  • 10
    • 0033112337 scopus 로고    scopus 로고
    • The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: The case of H2-receptor antagonists
    • (1999) Med Care , vol.37 , pp. 424-430
    • Andrade, S.E.1    Gurwitz, J.H.2    Fish, L.S.3
  • 12
    • 0032442967 scopus 로고    scopus 로고
    • Prescription to over-the-counter switch: A regulatory perspective
    • (1998) Clin Ther , vol.20 , Issue.SUPPL. C
    • Juhl, R.P.1
  • 16
    • 0010124408 scopus 로고    scopus 로고
    • Presentation to the FDA Nonprescription Drugs Advisory Committee, July 14, 2000. Rockville, Md.: FDA Dockets. transcripts
    • (2000) OTC rationale for Pravachol
  • 17
    • 0010191118 scopus 로고    scopus 로고
    • Presentation to the FDA Nonprescription Drugs Advisory Committee, July 13, 2000. Rockville, Md.: FDA Dockets. transcripts
    • (2000) OTC rationale for Mevacor
  • 18
    • 0033518849 scopus 로고    scopus 로고
    • Postmarketing surveillance and adverse drug reactions: Current perspectives and future needs
    • (1999) JAMA , vol.281 , pp. 824-829
    • Brewer, T.1    Colditz, G.A.2
  • 20
    • 0031225237 scopus 로고    scopus 로고
    • Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals
    • (1997) Clin Infect Dis , vol.25 , pp. 584-599
    • Shlaes, D.M.1    Gerding, D.N.2    John J.F., Jr.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.